Abstract:BACKGROUND:p16 Methylation is a potential biomarker for prediction of malignant transformation of epithelial dysplasia. A probe-based, quantitative, methylation-specific PCR (MSP) called MethyLight may become an eligible method for detecting this marker clinically. We studied oral mucosa biopsies with epithelial dysplasia from 78 patients enrolled in a published 4-years' followup cohort, in which cancer risk for patients with p16 methylation-positive dysplasia was significantly higher than those without p16 methylation (by 150-bp MSP and bisulfite sequencing; +133 ~ +283, transcription starting site, +1). The p16 methylation status in samples (N = 102) containing sufficient DNA was analyzed by the 70-bp classic (+238 ~ +307) and 115-bp novel (+157 ~ +272) MethyLight assays, respectively.RESULTS:p16 Methylation was detectable in 75 samples using the classic MethyLight assay. The methylated-p16 positive rate and proportion of methylated-p16 by the MethyLight in MSP-positive samples were higher than those in MSP-negative samples (positive rate: 37/44 vs. 38/58, P=0.035, two-sided; proportion [median]: 0.78 vs. 0.02, P <0.007). Using the published results of MSP as a golden standard, we found sensitivity, specificity, and accuracy for this MethyLight assay to be 70.5%, 84.5%, and 55.0%, respectively. Because amplicon of the classic MethyLight procedure only partially overlapped with the MSP amplicon, we further designed a 115-bp novel MethyLight assay in which the amplicon on the sense-strand fully overlapped with the MSP amplicon on the antisense-strand. Using the 115-bp MethyLight assay, we observed methylated-p16 in 26 of 44 MSP-positive samples and 2 of 58 MSP-negative ones (P = 0.000). These results were confirmed with clone sequencing. Sensitivity, specificity, and accuracy using the 115-bp MethyLight assay were 59.1%, 98.3%, and 57.4%, respectively. Significant differences in the oral cancer rate were observed during the followup between patients (≥60 years) with and without methylated-p16 as detected by the 115-bp MethyLight assay (6/8 vs. 6/22, P = 0.034, two-sided).CONCLUSIONS:The 115-bp MethyLight assay is a useful and practical assay with very high specificity for the detection of p16 methylation clinically.

Highly sensitive determination of the methylated p16 gene in cancer patients by microchip electrophoresis.

A Novel Method of Microarray Quantitave Analysis of P16 CPG Island Methylation in Leukemia Cells from Patients with Hematological Malignancies.

Detection Of Methylation Of Human P16(Ink4a) Gene 5 '-Cpg Islands By Electrochemical Method Coupled With Linker-Pcr

Microarray-based Method for Detecting Methylation Changes of P16^ink4a Gene 5＇-Cpg Islands in Gastric Carcinomas

Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients.

Absolute quantification of DNA methylation using microfluidic chip-based digital PCR

Microarray-based method for detecting methylation changes of p16Ink4a gene 5'-CpG islands in gastric carcinomas

A 115-Bp MethyLight Assay for Detection of P16 (CDKN2A) Methylation As a Diagnostic Biomarker in Human Tissues

Study of P16 Tumor Suppressor Gene with Methylation-Specific PCR

High-throughput Method for Detecting DNA Methylation

Sensitive colorimetric biosensing for methylation analysis of p16/CDKN2 promoter with hyperbranched rolling circle amplification.

Detection of p16 Hypermethylation in Gastric Carcinomas Using a Seminested Methylation-Specific PCR

Detection of Hypermethylation of P16 Gene from Colorectal Cancer Patient

A methyl at ion-specific oligonucleotide microarray for quantitative analysis of p16 gene

Detection of P16 Gene Methylation by Methylation-Specific PCR and Its Clinical Significance in Lung Cancer

Analysis of p16 hypermethylation in sputum samples from elderly patients with lung cancer

Diagnostic value of detection of hypermethylation of p16 gene in peripheral lung carcinoma

Colorimetric silver detection of methylation using DNA microarray coupled with linker-PCR.

Single copy-sensitive electrochemical assay for circulating methylated DNA in clinical samples with ultrahigh specificity based on a sequential discrimination-amplification strategy

Methylation Pattern Analysis Using High‐throughput Microarray of Solid‐phase Hyperbranched Rolling Circle Amplification Products

Quantitate Detect of the Methylation of Three Hematopathy Patients’ P16 Gene